Printer Friendly
The Free Library
14,635,740 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Schein Pharmaceutical, Inc. expands anti-viral portfolio with introduction of Acyclovir.


FLORHAM PARK, NJ--(BUSINESS WIRE)--April 14, 1997--Schein Pharmaceutical, Inc., will be introducing Acyclovir acyclovir /acy·clo·vir/ (a-si´klo-ver) a synthetic purine nucleoside with selective activity against herpes simplex virus; used as the base or the sodium salt in the treatment of genital and mucocutaneous herpesvirus infections.  Capsules and Tablets immediately upon patent expiration -- adding the first oral solid anti-viral product to the company's growing anti-viral portfolio.

Acyclovir, comparable to Glaxo Wellcome's Zovirax(R), is available from Schein through a marketing agreement with LEK Pharmaceutical and Chemical Company d.d., a world class manufacturer of bulk raw materials and finished dosage forms A dosage form is the physical form of a dose of medication, such as a capsule or injection. The route of administration is dependent on the dosage form of a given drug. .

"The introduction of Acyclovir marks a significant move in our effort to continuously broaden the range of our therapeutic offerings and demonstrates the customer value afforded by our relationship with LEK Pharmaceutical -- combining their expertise in raw material and finished dosage production with Schein's established U.S. infrastructure," said Martin Sperber, Chairman and Chief Executive Officer of Schein Pharmaceutical.

In addition to marketing Acyclovir, Schein manufactures and markets another anti-viral product, Trifluridine Ophthalmic Solution ophthalmic solution
n.
A sterile solution that is free from foreign particles and is compounded and dispensed for eyedrops.
, the only available generic formulation comparable to Glaxo Wellcome's Viroptic(R).

Schein Pharmaceutical, Inc., is one of the leading multisource companies in the U.S., employing over 1,800 people at eight facilities located in Florham Park, NJ; Carmel, NY; Brewster, NY; Danbury, CT; Phoenix, AZ; Humacao, PR; and Cherry Hill Cherry Hill, township (1990 pop. 69,319), Camden co., W central N.J.; name was changed from Delaware township to Cherry Hill in 1961. Largely residential, Cherry Hill has been marked by great development and housing growth, especially since the 1970s. , NJ. Schein has recently been cleared to market 10 new products to add to their existing line of over 400 manufactured and marketed pharmaceutical products in nearly every therapeutic category. In addition to commercializing generic products, Schein is committed to building a brand pharmaceutical presence in niche therapeutic areas. The company maintains modern manufacturing facilities, invests significantly in product development, and focuses on controlling health care costs through state-of-the-art production, distribution and competitive pricing of quality merchandise.

LEK Pharmaceutical and Chemical Company d.d. is the leading Slovene pharmaceutical company, recognized as a mid-sized company by world standards. Over 75 percent of the company's products are exported throughout 80 countries worldwide with over 2,200 product licenses. LEK is a vertically integrated pharmaceutical manufacturer with state-of-the-art expertise in organic synthesis Organic synthesis is the construction of organic molecules via chemical processes. Organic molecules can often contain a higher level of complexity compared to purely inorganic compounds, so the synthesis of organic compounds has developed into one of the most important aspects of , fermentation fermentation, process by which the living cell is able to obtain energy through the breakdown of glucose and other simple sugar molecules without requiring oxygen. Fermentation is achieved by somewhat different chemical sequences in different species of organisms.  and environmental control. LEK's products are manufactured and marketed in 10 major therapeutic categories in all respective galenic Ga`len´ic

a. 1. Pertaining to, or containing, galena.
1. Relating to

Galen ersfn> or to his principles and method of treating diseases.
 forms. LEK has been active in the U.S. market since the late 1970s and complies with all U.S., FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 and cGMP requirements.

CONTACT: Schein Pharmaceutical

Suzanne Soderberg, 201/593-5565
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 14, 1997
Words:374
Previous Article:OTG Software announces DiskExtender 3.2 for Windows NT.
Next Article:Rockwell Semiconductor Systems forms Network Access Division.
Topics:



Related Articles
Hardy viruses survive drug assault.
New cold sore cream on the market.(penciclovir)(Brief Article)
Bats may spread new Malaysian virus.(encephalitis outbreak)(Brief Article)
Suppressive drug therapy hinders herpes. (Biomedicine).(daily usage of valacyclovir)(Brief Article)
PLAYING WIND INSTRUMENTS CAN BE CAUSE OF DENTAL DISHARMONY.(L.A. LIFE)
Vanquishing a virus; new drugs attack herpes infections.(Brief Article)
Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs.(Research)
Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient.(Dispatches)
The hepatitis C drug development pipeline.(HCV Pipeline)
TELBIVUDINE APPROVED IN SWITZERLAND FOR CHRONIC HEPATITIS B.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles